Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
11,466,013
-
Share change
-
+257,265
-
Total reported value
-
$235,163,235
-
Put/Call ratio
-
68%
-
Price per share
-
$20.51
-
Number of holders
-
86
-
Value change
-
+$3,997,088
-
Number of buys
-
41
-
Number of sells
-
31
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q1 2018
As of 31 Mar 2018 REATA PHARMACEUTICALS INC - CL A (RETA) had 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,466,013 shares of stock of the company.
Largest 10 holders included CPMG Inc, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, EMERALD ADVISERS INC/PA, EMERALD MUTUAL FUND ADVISERS TRUST, Cormorant Asset Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Boxer Capital, LLC, and Prosight Management, LP.
This table shows 86 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.